Free Submission Public Relations & NewsPR-inside.com
Home
Deutsch English

Health

Market Report, "Constipation - Pipeline Review, H1 2013", published


Print article Print article
2013-04-02 17:57:36 - New Pharmaceuticals market report from Global Markets Direct: "Constipation - Pipeline Review, H1 2013"

Global Markets Direct's, 'Constipation - Pipeline Review, H1 2013', provides an overview of the indication's therapeutic pipeline. This report provides information on the therapeutic development for Constipation, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Constipation. Constipation - Pipeline Review, Half Year is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team.


Full Report Details at
- www.fastmr.com/prod/556443_constipation_pipeline_review_h1_2013. ..


Note*: Certain sections in the report may be removed or altered based on the availability and relevance of

data for the indicated disease.

Scope

* A snapshot of the global therapeutic scenario for Constipation.
* A review of the Constipation products under development by companies and universities/research institutes based on information derived from company and industry-specific sources.
* Coverage of products based on various stages of development ranging from discovery till registration stages.
* A feature on pipeline projects on the basis of monotherapy and combined therapeutics.
* Coverage of the Constipation pipeline on the basis of route of administration and molecule type.
* Key discontinued pipeline projects.
* Latest news and deals relating to the products.

Reasons to buy

* Identify and understand important and diverse types of therapeutics under development for Constipation.
* Identify emerging players with potentially strong product portfolio and design effective counter-strategies to gain competitive advantage.
* Plan mergers and acquisitions effectively by identifying players of the most promising pipeline.
* Devise corrective measures for pipeline projects by understanding Constipation pipeline depth and focus of Indication therapeutics.
* Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
* Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline.

Partial Table of Contents:

Table of Contents
Table of Contents
List of Tables
List of Figures
Introduction
Global Markets Direct Report Coverage
Constipation Overview
Therapeutics Development
An Overview of Pipeline Products for Constipation
Constipation Therapeutics under Development by Companies
Constipation Therapeutics under Investigation by Universities/Institutes
Late Stage Products
Comparative Analysis
Mid Clinical Stage Products
Comparative Analysis
Early Clinical Stage Products
Comparative Analysis
Pre-Clinical Stage Products
Comparative Analysis
Constipation Therapeutics - Products under Development by Companies
Constipation Therapeutics - Products under Investigation by Universities/Institutes
Companies Involved in Constipation Therapeutics Development
AstraZeneca PLC
Dainippon Sumitomo Pharma Co., Ltd.
Dong-A Pharmaceutical Co., Ltd.
Kissei Pharmaceutical Co., Ltd.
Shire Plc
Yuhan Corporation
Theravance, Inc.
Sucampo Pharmaceuticals, Inc.
Ironwood Pharmaceuticals, Inc.
Braintree Laboratories, Inc.
Ferring Pharmaceuticals, Inc.
MicroDose Therapeutx, Inc.
Beech Tree Labs, Inc.
Constipation - Therapeutics Assessment
Assessment by Monotherapy Products
Assessment by Route of Administration
Assessment by Molecule Type
Drug Profiles
prucalopride - Drug Profile
Product Description
Mechanism of Action
R&D Progress
linaclotide - Drug Profile
Product Description
Mechanism of Action
R&D Progress
lubiprostone - Drug Profile
Product Description
Mechanism of Action
R&D Progress
MDT-006 - Drug Profile
Product Description
Mechanism of Action
R&D Progress
velusetrag - Drug Profile
Product Description
Mechanism of Action
R&D Progress
YKP-10811 - Drug Profile
Product Description
Mechanism of Action
R&D Progress
elobixibat - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Drug For Chronic Constipation - Drug Profile
Product Description
Mechanism of Action
R&D Progress
DA-6886 - Drug Profile
Product Description
Mechanism of Action
R&D Progress
BLI-801 - Drug Profile
Product Description
Mechanism of Action
R&D Progress
AZD-1722 - Drug Profile
Product Description
Mechanism of Action
R&D Progress
YH-12852 - Drug Profile
Product Description
Mechanism of Action
R&D Progress
DSP-6952 - Drug Profile
Product Description
Mechanism of Action
R&D Progress
KWA-0711 - Drug Profile
Product Description
Mechanism of Action
R&D Progress
mexiletine hydrochloride - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Constipation Therapeutics - Drug Profile Updates
Constipation Therapeutics - Discontinued Products
Constipation Therapeutics - Dormant Products
Constipation - Product Development Milestones
Featured News & Press Releases
Nov 06, 2012: RaQualia Completes 5-HT4 Partial Agonist Phase I Study
Oct 22, 2012: Synergy Pharma Highlights Mechanistic Features Of Plecanatide At ACG 2012 And UEG Week
Sep 21, 2012: Ironwood Pharma's Linaclotide Receives Positive CHMP Opinion For Treatment Of IBS-C

Full Table of Contents is available at:
-- www.fastmr.com/catalog/product.aspx?productid=556443&dt=t

About Global Markets Direct

Global Markets Direct is a leading provider of global business intelligence and market analysis. It publishes a range of high quality company and market reports created by its large research and analysis capability and drawing from its extensive unique databases of industry-specific information. View more research from Global Markets Direct at www.fastmr.com/catalog/publishers.aspx?pubid=1033

About Fast Market Research

Fast Market Research is an online aggregator and distributor of market research and business information. We represent the world's top research publishers and analysts and provide quick and easy access to the best competitive intelligence available.

For more information about these or related research reports, please visit our website at www.fastmr.com or call us at 1.800.844.8156.


Author:
Bill Thompson
e-mail
Web: www.fastmr.com
Phone: 18008448156

Disclaimer: If you have any questions regarding information in these press releases please contact the company added in the press release. Please do not contact pr-inside. We will not be able to assist you. PR-inside disclaims contents contained in this release.
Latest News
Read the Latest News
www.newsenvoy.com

 


Terms & Conditions | Privacy | About us | Contact PR-inside.com